Business
Pulse Biosciences’ nPulse™ Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium
nPulse Cardiac Catheter for AF ablation to be highlighted in late-breaking clinical science session and in a live case transmission HAYWARD,
About this update from Pulse Biosciences, Inc
[{"type":"text","content":"\nnPulse Cardiac Catheter for AF ablation to be highlighted in late-breaking clinical science session and in a live case transmission\n\n\n HAYWARD, Calif.--(BUSINESS WIRE)--\nPulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced its nPulse technology will be featured in a late-breaking science session and a live case transmission featuring the nPulse Cardiac Catheter integrated with Abbott’s EnSiteX™ 3D Mapping System at the 31st Annual AF Symposium 2026 meeting, being held February 5-7 in Boston, Massachusetts.\n\n\n“We are pleased to share 6-month and 12-month follow-up data from our Cardiac Catheter Human Feasibility Study in Europe. The data are expected to highlight the disruptive potential of nanosecond PFA for the treatment of atrial fibrillation,” said Paul LaViolette, Co-Chairman of Pulse Biosciences’ Board of Directors. “This is an exciting milestone for Pulse Biosciences, and I would like to thank our team, the clinicians and the patients for their contributions to this seminal data set. We look forward to engaging with the entire clinical community at this important meeting.”\n\n\nKey nPulse Technology Scientific Programming\n\n\nThursday, February 5th\n\n\n\n5:00-7:00pm, Vivek Reddy, MD – Late Breaking Clinical Science Session\n\n\n\nTitle: Nanosecond Pulse Field Ablation Using a Compliant Circular Catheter to Treat Atrial Fibrillation: A Multicenter Experience\n\n\n\nReview of the first 150 patients treated including 6- and 12-month follow-up for a subset of patients in a feasibility study with the nPulse Cardiac Catheter at three European centers.\n\n\n\nFriday, February 6th and Saturday, February 7th\n\n\n\nPoster Presentation\n\n\n\nTitle: Nanosecond Pulses Generate Deeper Cardiac Lesions Compared to Microsecond Pulses at Matched Energy\n\n\n\nPresentation of a preclinical study showing that cardiac tissue ablations using nanosecond pulsed electric fields produced significantly deeper lesions compared with microsecond pulses utilizing the same electrode and with matched energy\n\n\n\nSaturday, February 7th\n\n\n\n7:30-9:30am, Petr Neuzil, MD, PhD, Jan Petru, MD, and Moritoshi Funasako MD, PhD (Na Homolce Hospital, Prague, Czech Republic) – Live Case Transmission\n\n\n\nT...